Integrative molecular medicine最新文献

筛选
英文 中文
The authenticity, sterility, and stability of culturing human pluripotent stem cells 培养人类多能干细胞的真实性、无菌性和稳定性
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/IMM.1000361
Hea-Jo Yoon, Woo Jung Ho
{"title":"The authenticity, sterility, and stability of culturing human pluripotent stem cells","authors":"Hea-Jo Yoon, Woo Jung Ho","doi":"10.15761/IMM.1000361","DOIUrl":"https://doi.org/10.15761/IMM.1000361","url":null,"abstract":"Cultivation of human pluripotent stem cells (hPSCs) is necessary for experimental demand or clinical application. The culture of human stem cells shares many of the same standards as mammalian somatic cell culture. Since the cells in culture are exposed to a different environment from the environment of the living body, the cells per se tend to adapt and adapt to the culture conditions. Particularly, they can be easily affected by external pathogen or culture environment because hPSCs are dynamic cells with pluripotency and regeneration ability [1]. In addition, the method of maintaining undifferentiated state during longterm culture without loss of regeneration ability or pluripotency may affect the characteristics of cells resulting in changes of the authenticity, and instability of hPSCs. Qualitative assessments during the culture of hPSCs include purity, viability, morphological appearance, confluency (the percentage of the surface of a culture dish that is covered by adherent cells), functionality, contamination and cross-contamination, authenticity, differentiation state, and identification of genetic stability [1]. Among them, the key elements of cultivation of hPSCs would be authenticity, sterility, and stability of cell lines [1,2].","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"109 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79205709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of adhesion molecules in nephropathies: The diagnostic applications 黏附分子在肾病中的作用:诊断应用
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/IMM.1000359
S. Uwaezuoke
{"title":"The role of adhesion molecules in nephropathies: The diagnostic applications","authors":"S. Uwaezuoke","doi":"10.15761/IMM.1000359","DOIUrl":"https://doi.org/10.15761/IMM.1000359","url":null,"abstract":"","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86126323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Expression of the Wnt antagonist Dickkopf-1 in endometriosis Wnt拮抗剂Dickkopf-1在子宫内膜异位症中的表达
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000379
M. Kasoha, L. Golbach, Panagiotis klavounos, S. Findeklee, I. Juhasz-Böss, H. Eichler, E. Solomayer
{"title":"Expression of the Wnt antagonist Dickkopf-1 in endometriosis","authors":"M. Kasoha, L. Golbach, Panagiotis klavounos, S. Findeklee, I. Juhasz-Böss, H. Eichler, E. Solomayer","doi":"10.15761/imm.1000379","DOIUrl":"https://doi.org/10.15761/imm.1000379","url":null,"abstract":"","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80829485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small molecule inhibition of NOX-1 reduces diabetes conversion in NOD mice 小分子抑制NOX-1可降低NOD小鼠的糖尿病转化
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000367
David S. Taylor, A. Pearson, Lindsey M. Glenn, Kara S Orr, S. Tersey, D. Taylor-Fishwick
{"title":"Small molecule inhibition of NOX-1 reduces diabetes conversion in NOD mice","authors":"David S. Taylor, A. Pearson, Lindsey M. Glenn, Kara S Orr, S. Tersey, D. Taylor-Fishwick","doi":"10.15761/imm.1000367","DOIUrl":"https://doi.org/10.15761/imm.1000367","url":null,"abstract":"Inflammation is a major contributor to beta cell destruction leading to diabetes. Generation of reactive oxygen species (ROS) by inflammatory signals facilitates beta cell dysfunction. Disruption of the ROS-generating enzyme NADPH oxidase-1 (NOX-1) confers protection to beta cells. Selective small molecule inhibitors of NOX-1 that confer protection to mouse or human beta cells (ML171 or GKT137831) have been systemically administered to NOD mice. A brief (4 week) administration of the NOX-1 inhibitors reduced the conversion of NOD mice to diabetes, relative to vehicle control. Histologic analysis of islet morphology showed mice administered the NOX-1 inhibitors had a predominant organization of leukocytes that was restricted to the peri-islet region, in contrast to leukocyte invasion of the islet that was predominantly seen in vehicle control mice. The data support the therapeutic potential of NOX-1 inhibition in diabetes and suggest a role for NOX-1 in the cross talk between inflammatory cells, beta cells and the integrity of the islet extracellular matrix.","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90645866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
System accuracy evaluation of the systems for self-monitoring of blood glucose GL50 evo and GL 44 following DIN EN ISO 15197:2015: A comparison of accuracy in glucose concentration ranges <100 mg/dL and ≥100 mg/dL 根据DIN EN ISO 15197:2015对血糖自我监测系统GL50 evo和GL 44的系统准确性评价:葡萄糖浓度范围< 100mg /dL和≥100mg /dL的准确性比较
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000383
E. Salzsieder, S. Berg, A. Puchert, E. Freyse
{"title":"System accuracy evaluation of the systems for self-monitoring of blood glucose GL50 evo and GL 44 following DIN EN ISO 15197:2015: A comparison of accuracy in glucose concentration ranges <100 mg/dL and ≥100 mg/dL","authors":"E. Salzsieder, S. Berg, A. Puchert, E. Freyse","doi":"10.15761/imm.1000383","DOIUrl":"https://doi.org/10.15761/imm.1000383","url":null,"abstract":"Ongoing standardized verification of the accuracy of blood glucose meters systems for self-monitoring post-launch is important clinically and helps confirm appropriate continues performance of self-monitoring blood glucose (SMBG) systems. In addition, publication of such studies is increasingly becoming a component of evidence-based purchase decision making. ISO 15197:2015,2 for which mandatory compliance is recommended for SMBG systems by 2015,3 has tighter accuracy requirements than ISO 15197:2003,4 and outlines current minimum accuracy standards necessary in Europe for CE marking. Introduction In the present study, a post marketing evaluation of the CE-marked GL50 evo and GL44 systems were performed in accordance with ISO 15197:2015 protocols and requirements. The GL50 evo and GL44 systems were supplied in Germany from the Beurer GmbH, Germany. A declaration of conformity from the manufacturer of the two measuring systems was available before the start of the study, so that only the GL50 evo was used in the tests, but the results documented the quality of both systems. Two GL50 evo systems (serial number: GL55 T1 and GL55 T2) and strips from 3 different lots (A 10/1, A 10/3, A 10/4) with expiry dates March 2017 respectively) were supplied by the manufacturer. The study was conducted from April 21 to May 05, 2015, at the Institute of Diabetes “Gerhardt Katsch,” Karlsburg, Germany. Ethical approval for the study was obtained from the Ethics Committee of the University of Greifswald in July 2014 [1-3]. Ear lobe capillary blood samples were taken from 118 subjects for duplicate glucose determination using the GL50 evo and the glucose oxidase based YSI2300 STAT PLUS (YSI Incorporated, Yellow Springs, Ohio, USA) plasma glucose reference method. Trueness and precision of the comparison assay were verified using a range of YSI bioanalytical standards and controls. The prescribed limits for the hematocrit values, to be between 20% and 60%, were reached by the patient samples and after examination of glucose concentration ranges using the YSI, 100 subjects were included in the analysis of accuracy [4]. In the glucose range <100 mg/dL in summary 98.8 % of the values and in the range ≥ 100 mg/dl in summary 98.6 % full filled the quality criteria of the ISO 15197. Important differences between the three tested lots were not shown; detailed data are presented in Tables 1 and *Correspondence to: Eckhard Salzsieder, Institute of Diabetes, Gerhardt Katsch, Karlsburg, Germany, E-mail: apuchert@diabetes-karlsburg.de","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"480 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78121109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of current diagnostic, prognostic, and therapeutic use of EEG and EEG-based markers of cognition, mental, and brain health 目前脑电图和基于脑电图的认知、精神和大脑健康标志物的诊断、预后和治疗应用概述
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000378
Priya Miranda, Christopher D Cox, Michael Alexander, S. Danev, J. Lakey
{"title":"Overview of current diagnostic, prognostic, and therapeutic use of EEG and EEG-based markers of cognition, mental, and brain health","authors":"Priya Miranda, Christopher D Cox, Michael Alexander, S. Danev, J. Lakey","doi":"10.15761/imm.1000378","DOIUrl":"https://doi.org/10.15761/imm.1000378","url":null,"abstract":"The global burden of cognitive, mental, neurological, and substance-use disorders at 258 million disability adjusted life years calls for immediate “action” in their prevention and management. The electroencephalogram (EEG) is one of the most widely-used instruments for the non-invasive neuro-physiological measure of brain function and health. The EEG was originally used to solely monitor and record electric waves generated by electrical activity in the brain to aid in clinical decision-making and diagnosis. Technological improvements have made it possible for state-of the-art EEG computer-based systems like NeuralScan by Medeia Inc. to evaluate changes in power and in ratios of these brain waves with changes in brain and mental health status. Today’s EEG machines can also identifying the precise localization of these changes enabling more accurate diagnosis and treatment. Improvements in EEG technology have made them robust, stationary/portable, high fidelity, versatile with the ability to carry out complex functions and calculations yet still be user/clinician-friendly highlighting their potential for use in clinical, research, epidemiological and public health settings. The present article presents an overview on EEG machines, their use in diagnosis, prognosis and therapy and to generate EEG-based markers in the area of cognition, mental and brain health. Introduction EEG in brain health and cognition Normal functioning of the cerebral cortex is critical to physiological, neurological and mental health. Currently, cognitive, mental, neurological, and substance-use diseases/disorders account for 258 million disability adjusted life years (10.4% total all cause DALYS). This reiterates the need for better prevention, diagnostic and treatment options for brain health that can be used in clinical, epidemiological and public health settings [1-2]. Among the diagnostic and assessment tools for brain health are the a) non-invasive: neuro-clinical-physical examinations, questionnaires /instruments, electroencephalogram EEG, neuroimaging including ultrasound, magnetic resonance imaging, MRI, functional MRI (fMRI), positron emission tomography (PET), and computerized tomography (CT); and b) the invasive: biochemical tests, genetic tests, cerebrospinal fluid (CSF) analysis, angiography, and biopsies. While the MRI, fMRI, PET and CT provide good spatial resolution of brain health, the EEG evaluates brain health via temporal resolution of brain function within the millisecond range [3-5], which is not possible with the other approaches. Due to its sensitivity to changes in brain function and structure and its simplicity of use in clinical settings, its use in intensive care has continued to increase in recent years [6-8]. The EEG assesses the neurophysiological aspects of brain function via the capture of the electric waves generated by electrical activity in the cerebral cortex. The cerebral cortex is divided into four lobes: the frontal, parietal, tempora","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"101 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89927194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The influence of albumin on the plasma xanthine oxidoreductase inhibitory activity of allopurinol, febuxostat and topiroxostat: Insight into extra-urate lowering effect 白蛋白对别嘌呤醇、非布司他和托吡司他血浆黄嘌呤氧化还原酶抑制活性的影响:对超尿酸降低作用的洞察
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/IMM.1000368
Takashi Nakamura, T. Murase, Etsuko Satoh, Atsushi Miyachi, N. Ogawa, K. Abe, Noriaki Katoh, Y. Nakayama
{"title":"The influence of albumin on the plasma xanthine oxidoreductase inhibitory activity of allopurinol, febuxostat and topiroxostat: Insight into extra-urate lowering effect","authors":"Takashi Nakamura, T. Murase, Etsuko Satoh, Atsushi Miyachi, N. Ogawa, K. Abe, Noriaki Katoh, Y. Nakayama","doi":"10.15761/IMM.1000368","DOIUrl":"https://doi.org/10.15761/IMM.1000368","url":null,"abstract":"","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78149729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Quantum chemistry molecular modeling for longevity: Importance of antioxidative effects in mitochondria as battery of cells 长寿的量子化学分子模型:线粒体作为细胞电池的抗氧化作用的重要性
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000380
S. Yanagida, K. Osabe, T. Nagai, Nobuyuki Murakami
{"title":"Quantum chemistry molecular modeling for longevity: Importance of antioxidative effects in mitochondria as battery of cells","authors":"S. Yanagida, K. Osabe, T. Nagai, Nobuyuki Murakami","doi":"10.15761/imm.1000380","DOIUrl":"https://doi.org/10.15761/imm.1000380","url":null,"abstract":"Background: Quantum chemistry, i.e., density functional theory-based molecular modeling (DFT/MM) using computer software of “Spartan” on personal computer is a novel analysis method for equilibrium geometry and energy structure of van der Waals force (vdW) aggregates of molecules. In view of the action of preventing disease, DFT/MM is undertaken to analyze redox reactions in mitochondria (mt) as battery of cells which is functioning using oxygen and D-glucose. Materials and methods: DFT-based molecular modeling (DFT/MM), equivalent to the quantum mechanics/molecular mechanics (QM/MM) method, was performed by using the B3LYP exchange-correlation function and the 6–31G(d) basis set with Spartan’16 (Wavefunction, Inc. Irvine, CA). Results: DFT/MM verifies and predicts that superoxide radical anion (O2) and hydrogen peroxide (HOOH) are produced by redox reactions of ground state oxygen (O2) and D-glucose in mt. Without exhausting ATP, accumulation of HOOH will start in mt, resulting in production of hazardous hydroxyl radical (HO dot). The hydroxyl radical (HO dot) destroys cellular membrane, leading to dysfunction of mt. Accumulation of HOOH and formation of hazardous HO radical will be suppressed by antioxidative chemical substance, e.g., Vitamin C, thyroxin (T4), and triiodothyronine (T3). Thyroid hormone is one of so-called super oxide dismutase, iodine atoms in which play an important role of antioxidative effects in mt. Conclusion: Dietary intake of antioxidative chemical substance like Vitamin C, preservation of acceptable level of iodine-bearing T4 and T3 in blood, and aerobic exercise which prevents accumulation of HOOH are essential for prolonged mt as battery of cells.","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72825219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The role of mitochondria in tumorigenesis 线粒体在肿瘤发生中的作用
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/imm.1000356
Mouza Mohammed AlFashti AlAleeli
{"title":"The role of mitochondria in tumorigenesis","authors":"Mouza Mohammed AlFashti AlAleeli","doi":"10.15761/imm.1000356","DOIUrl":"https://doi.org/10.15761/imm.1000356","url":null,"abstract":"The maternal inheritance of the mitochondrial DNA is one of its amazing characteristics. It is located in the matrix of a mitochondrion. The cellular organelle that is responsible for the generation of ATPs is the mitochondrion. A lot of studies have linked the mitochondria with the generation of cancer cells. There is a crosstalk in the medical research field that whether the cancer cells were originated from a nuclear defect or from a mitochondrial dysfunction. In this review paper, I will highlight the role of mitochondria in tumorigenesis.","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73827501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breakthrough: PAK1-dependent expression of PD-L1 (programmed death ligand) 突破:PD-L1(程序性死亡配体)的pak1依赖性表达
Integrative molecular medicine Pub Date : 2019-01-01 DOI: 10.15761/IMM.1000353
H. Maruta
{"title":"Breakthrough: PAK1-dependent expression of PD-L1 (programmed death ligand)","authors":"H. Maruta","doi":"10.15761/IMM.1000353","DOIUrl":"https://doi.org/10.15761/IMM.1000353","url":null,"abstract":"","PeriodicalId":94322,"journal":{"name":"Integrative molecular medicine","volume":"134 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78102442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信